cancer immunotherapy Archives

Stanford University School of Medicine blog

New advances toward safely targeting immune cells to pediatric brain tumors

Stanford scientists have taken important steps toward figuring out how to use immune therapy for a group of severe pediatric brain tumors.

Pioneering immunotherapy drug gets new testing for early prostate cancer

Pioneering immunotherapy drug Provenge is enjoying a revival, thanks to a large new clinical trial that will test it in men with early prostate cancer.

Engineered immune cells clear deadly pediatric brain tumor in mice

Scientists have made an important step forward in treating a deadly childhood brain tumor, using T cells engineered to target a surface sugar found on the cancer cells.

In pre-clinical study, Stanford researchers use cancer “vaccine” to eliminate tumors

Stanford researchers led work on a possible cancer vaccine that involves injecting two immune-stimulating agents directly into solid tumors.